FDA Takes Action on Updated mRNA COVID-19 Vaccines ...
Approval of Spikevax (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, a change to a single dose for individuals 18 years of age and older, and approval of a single dose for …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty or the updated, approved Spikevax; if previously vaccinated, the dose is...
FDA authorizes Novavax's updated Covid vaccine targeting JN.1 …
Novavax’s traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA — Moderna’s Spikevax and Comirnaty, which is jointly developed …
Moderna Files FDA Application for the JN.1 Targeting ...
Jun 7, 2024 · CAMBRIDGE, MA / ACCESSWIRE / June 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and …
Spikevax (COVID-19 Vaccine, mRNA) 2024-2025 Formula - Moderna
Learn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2024-2025 Formula and how it helps protect against emerging variants, following ACIP recommendation.
Coronavirus (COVID-19) Update: FDA Takes Key Action by …
Jan 31, 2022 · Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved …
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Sep 11, 2023 · SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute …
Moderna Receives Full U.S. FDA Approval for COVID-19 ...
Jan 31, 2022 · Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax. Approval based on a comprehensive submission package including efficacy and safety data …
MHRA approves Spikevax JN.1 COVID-19 vaccines for adults and …
Sep 2, 2024 · The MHRA has approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant. On 2 September 2024, The Medicines and Healthcare …
Spikevax (previously COVID-19 Vaccine Moderna)
Jan 6, 2021 · Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The use of this vaccine should be in …